Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Patients With Metastatic Breast Cancer: Duration of Effect
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer With Bone Involvement
Interventions: DRUG: Zoledronic acid
Sponsor: University Health Network, Toronto
Collaborators: Canadian Breast Cancer Foundation